| __timestamp | Eli Lilly and Company | Geron Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 6620800000 | 16758000 |
| Thursday, January 1, 2015 | 6533000000 | 17793000 |
| Friday, January 1, 2016 | 6452000000 | 18761000 |
| Sunday, January 1, 2017 | 6588100000 | 19287000 |
| Monday, January 1, 2018 | 5975100000 | 18707000 |
| Tuesday, January 1, 2019 | 6213800000 | 20893000 |
| Wednesday, January 1, 2020 | 6121200000 | 25678000 |
| Friday, January 1, 2021 | 6431600000 | 29665000 |
| Saturday, January 1, 2022 | 6440400000 | 43628000 |
| Sunday, January 1, 2023 | 6941200000 | 69135000 |
| Monday, January 1, 2024 | 8593800000 |
Igniting the spark of knowledge
In the competitive landscape of pharmaceuticals, managing Selling, General, and Administrative (SG&A) expenses is crucial for maintaining profitability. Over the past decade, Eli Lilly and Company has consistently demonstrated robust control over its SG&A costs, averaging around $6.4 billion annually. In contrast, Geron Corporation, a smaller player, has managed its SG&A expenses at a much lower scale, averaging approximately $28 million per year.
From 2014 to 2023, Eli Lilly's SG&A expenses showed a steady trend with a slight increase of about 5% over the period, peaking in 2023. Meanwhile, Geron Corporation experienced a more significant rise, with its SG&A costs surging by over 300% during the same timeframe. This stark difference highlights Eli Lilly's efficiency in managing operational costs compared to Geron, which may be attributed to its larger scale and more established market presence.
Selling, General, and Administrative Costs: Eli Lilly and Company vs Pharming Group N.V.
Operational Costs Compared: SG&A Analysis of Eli Lilly and Company and Axsome Therapeutics, Inc.
Comparing SG&A Expenses: Eli Lilly and Company vs Merus N.V. Trends and Insights
Eli Lilly and Company vs Geron Corporation: Examining Key Revenue Metrics
SG&A Efficiency Analysis: Comparing Eli Lilly and Company and Vericel Corporation
SG&A Efficiency Analysis: Comparing Takeda Pharmaceutical Company Limited and Geron Corporation
SG&A Efficiency Analysis: Comparing Bio-Techne Corporation and Geron Corporation
Madrigal Pharmaceuticals, Inc. and Geron Corporation: SG&A Spending Patterns Compared
Corcept Therapeutics Incorporated and Geron Corporation: SG&A Spending Patterns Compared
Arrowhead Pharmaceuticals, Inc. and Geron Corporation: SG&A Spending Patterns Compared
ImmunityBio, Inc. or Geron Corporation: Who Manages SG&A Costs Better?
Breaking Down SG&A Expenses: Agios Pharmaceuticals, Inc. vs Geron Corporation